首页> 外文期刊>Cytokine >Sulfatase 1 mediates the attenuation of Ang II-induced hypertensive effects by CCL5 in vascular smooth muscle cells from spontaneously hypertensive rats
【24h】

Sulfatase 1 mediates the attenuation of Ang II-induced hypertensive effects by CCL5 in vascular smooth muscle cells from spontaneously hypertensive rats

机译:硫酸酶1介导CCL5在来自自发性高血压大鼠血管平滑肌细胞中CCL5诱导的Ang II诱导的高血压作用的衰减

获取原文
获取原文并翻译 | 示例
       

摘要

Extracellular sulfatases, sulfatase 1 (Sulf1) and sulfatase 2 (Sulf2), play a pivotal role in cell signaling and carcinogenesis. Chemokine CCL5 inhibits Ang II-induced hypertensive mediators via angiotensin II (Ang II) type 2 receptor (AT2R) pathway in vascular smooth muscle cells (VSMCs) from spontaneously hypertensive rats (SHR). In this study, we investigated the effect of Sulfs on anti-hypertensive effects of CCL5 in SHR VSMCs. CCL5 attenuated Ang II-induced inhibition of sulfatase activity in SHR VSMCs. Inhibition of Ang II-induced 12-lipoxygenase (12-LO) and endothelin-1 (ET-1) expression by CCL5 was reduced in Sulf1 small interfering RNA (siRNA)-transfected SHR VSMCs. In addition, attenuation of Ang II-induced dimethylarginine dimethylaminohydrolase-1 (DDAH-1) inhibition by CCL5 was reduced in Sulf1 siRNA-transfected SHR VSMCs. Downregulation of Sulf2 did not affect inhibitory effects of CCL5 on Ang II-induced 12-LO and ET-1 expression and Ang II-induced inhibition of DDAH-1 expression in SHR VSMCs. Downregulation of Sulf1 abrogated the expression of CCL5-induced AT2R messenger RNA (mRNA) and synergistic effect of CCL5 on Ang II-induced AT2R expression in SHR VSMCs. These findings suggest that Sulf1 is a potential up-regulatory factor in anti-hypertensive actions of CCL5 via AT2R pathway on Ang II-induced hypertensive effects in SHR VSMCs.
机译:细胞外硫酸酶,硫酸酶1(SULF1)和硫酸酶2(SULF2),在细胞信号传导和致癌中起着枢转作用。趋化因子CCL5通过血管紧张素II(Ang II)2型受体(AT2R)途径抑制Ang II诱导的高血压介质,其来自自发性高血压大鼠(SHR)的血管平滑肌细胞(VSMC)。在这项研究中,我们研究了SULF对SHS VSMC中CCL5抗高血压作用的影响。 CCL5衰减Ang II诱导ShSMC中硫酸酶活性的抑制。在Sulf1小干扰RNA(siRNA) - 重染的SHSMC中,降低了CCL5的Ang II诱导的12-脂氧合酶(12-LO)和内皮素-1(ET-1)表达的抑制。此外,ClF1 siRNA转染的SHSMCs中,CCl5降低了Ang II诱导的二甲基喹甲磺酰基氨基酰氯酶-1(DDAH-1)抑制的衰减。 Sulf2的下调不影响CCl5对Ang II诱导的12-LO和ET-1表达和Ang II诱导的ShR VSMC中DDAH-1表达抑制的抑制作用。 Sulf1的下调废除了CCl5诱导的AT2R信使RNA(mRNA)的表达和CCL5在Ang II诱导的SHR VSMC中的AT2R表达的协同作用。这些发现表明,SULF1是CCL5通过AT2R途径的抗高血压作用潜在的升高调节因子,AT2R途径在ACH II诱导的SHR VSMC中的高血压作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号